EUVIMEDEUVIMED entdecken
Systematische Übersicht

Identification of most representative hub-genes for diagnosis, prognosis, and therapies of hepatocellular carcinoma

Md Alim Hossen, Md Selim Reza, Md Masud Rana, Md Bayazid Hossen, Muhammad Shoaib, Md Nurul Haque Mollah, Chunsheng Han

Chinese Clinical Oncology · 2024

DOI: 10.21037/cco-23-151 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Chinese Clinical Oncology, 2024. Verfasst von Md Alim Hossen und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China; Institute for Stem Cel…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths globally. To reduce HCC-related mortality, early diagnosis and therapeutic improvement are essential. Hub differentially expressed genes (HubGs) may serve as potential diagnostic and prognostic biomarkers, also offering therapeutic targets for precise therapies. Therefore, we aimed to identify top-ranked hub genes for the diagnosis, prognosis, and therapy of HCC. METHODS: Through a systematic literature review, 202 HCC-related HubGs were derived from 59 studies, yet consistent detection across these was lacking. Then, we identified top-ranked HubGs (tHubGs) by integrated bioinformatics analysis, highlighting their functions, pathways, and regulators that might be more representative of the diagnosis, prognosis, and therapies of HCC. RESULTS: In this study, eight HubGs (CDK1, AURKA, CDC20, CCNB2, TOP2A, PLK1, BUB1B, and BIRC5) were identified as the tHubGs through the protein-protein interaction (PPI) network and survival analysis. Their differential expression in different stages of HCC, validated using The Cancer Genome Atlas (TCGA) Program database, suggests their potential as early HCC markers. The enrichment analyses revealed some important roles in HCC-related biological processes (BPs), molecular functions (MFs), cellular components (CCs), and signaling pathways. Moreover, the gene regulatory network analysis highlighted key transcription factors (TFs) and microRNAs (miRNAs) that regulate these tHubGs at transcriptional and post-transcriptional. Finally, we selected three drugs (CD437, avrainvillamide, and LRRK2-IN-1) as candidate drugs for HCC treatment as they showed strong binding with all of our proposed and published protein receptors. CONCLUSIONS: The findings of this study may provide valuable resources for early diagnosis, prognosis, and therapies for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansPrognosisProtein Interaction MapsComputational BiologyBiomarkers, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Hepatocellular carcinoma (HCC)drug repurposinghub-genesmolecular docking (MD)

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China; Beiji…
  • Tulane Center of Biomedical Informatics and Genomics, School of Medicine, Tulane University, New Orleans, LA, USA.
  • The University of Chinese Academy of Sciences, Beijing, China; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China; China National Center for…
  • Department of Agricultural and Applied Statistics, Bangladesh Agricultural University, Mymensingh, Bangladesh.
  • Bioinformatics Lab, Department of Statistics, University of Rajshahi, Rajshahi, Bangladesh.

Zitieren

APA

Hossen, M. A., Reza, M. S., Rana, M. M., Hossen, M. B., Shoaib, M., Mollah, M. N. H., & Han, C. (2024). Identification of most representative hub-genes for diagnosis, prognosis, and therapies of hepatocellular carcinoma. Chinese Clinical Oncology. https://doi.org/10.21037/cco-23-151

Vancouver

Hossen MA, Reza MS, Rana MM, Hossen MB, Shoaib M, Mollah MNH, et al. Identification of most representative hub-genes for diagnosis, prognosis, and therapies of hepatocellular carcinoma. Chinese Clinical Oncology. 2024. doi:10.21037/cco-23-151

BibTeX
@article{Hossen2024,
  author = {Hossen, Md Alim and Reza, Md Selim and Rana, Md Masud and Hossen, Md Bayazid and Shoaib, Muhammad and Mollah, Md Nurul Haque and Han, Chunsheng},
  title = {Identification of most representative hub-genes for diagnosis, prognosis, and therapies of hepatocellular carcinoma},
  journal = {Chinese Clinical Oncology},
  year = {2024},
  doi = {10.21037/cco-23-151}
}
Kostenlos starten →